Trials / Terminated
TerminatedNCT02498275
Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is an exploratory study to characterize the ex vivo immune response to RO6871765 or RO7011785 stimulation of peripheral blood mononuclear cells (PBMCs) extracted from healthy volunteers and chronic hepatitis B (CHB) patients.
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2015-07-15
- Last updated
- 2016-11-07
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02498275. Inclusion in this directory is not an endorsement.